Therapeutic efficacy of liposomal clofazimine against Mycobacterium avium complex in mice depends on size of initial inoculum and duration of infection

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 1, 1997, Pages 17-23

  Kansal, Rita G ^a   Gomez Flores, Ricardo ^a   Sinha, Indu ^a   Mehta, Reeta T ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOFAZIMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; CELL VIABILITY; CHRONIC DISEASE; CONTROLLED STUDY; DRUG EFFICACY; GROWTH INHIBITION; IMMUNE RESPONSE; INFECTION CONTROL; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM AVIUM; NONHUMAN; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM;

EID: 0031030680     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.1.17     Document Type: Article

References (38)

1. Abrams, D. I., T. F. Mitchell, C. C. Child, S. C. Shiboski, C. L. Brosgart, and M. M. Mass. 1993. Clofazimine as prophylaxis for disseminated Mycobacterium avium complex infection in AIDS. J. Infect. Dis. 167:1459-1463.
2. Alving, C. R. 1983. Delivery of liposome encapsulated drugs to macrophages. Pharmacol. Ther. 22:407-424.
3. Alving, C. R., and G. M. Swartz, Jr. 1994. Preparation of liposomes for use as drug carriers in the treatment of leishmaniasis, p. 55-68. In G. Gregoriadis (ed.), Liposome technology, vol. 2. CRC Press, Inc., Boca Raton, Fla.
4. Appelberg, R., A. G. Castro, J. Pedrosa, R. A. Silva, I. M. Orme, and P. Minoprio. 1994. Role of gamma Interferon and tumor necrosis factor alpha during T-cell-independent and -dependent phases of Mycobacterium avium infection. Infect. Immun. 62:3962-3971.
5. Appelberg, R., A. Sarmento, and A. G. Castro. 1995. Tumor necrosis factor-alpha (TNF-α) in the host resistance to mycobacteria of distinct virulence. Clin. Exp. Immunol. 101:308-313.
6. Ausina, V., M. J. Condom, B. Mirelis, M. Luquin, P. Coll, and G. Prats. 1986. In vitro activity of clofazimine against rapidly growing nonchromogenic mycobacteria. Antimicrob. Agents Chemother. 29:951-952.
7. Barry, V. C., J. G. Belton, M. L. Conalty, et al. 1957. A new series of phenazines with high antituherculous activity. Nature 179:1013-1015.
8. Benson, C. A. 1994. Treatment of disseminated disease due to M. avium complex in patients with AIDS. Clin. Infect. Dis. 18(Suppl. 3):S237-S242.
9. Bermudez, L. E. M., and L. S. Young. 1988. Tumor necrosis factor, alone or in combination with IL-2, hut not IFN-γ, is associated with macrophage killing of Mycobacierium avium complex. J. Immunol. 140:3006-3013.
10. Bermudez, L. E. M., J. Martinelli, M. Petrofsky, P. Kolonoski, and L. S. Young. 1994. Recombinant granulocyte-macrophage colony stimulating factor enhances the effects of antibiotics against Mycobacterium avium complex. infection in the beige mouse model. J. Infect. Dis. 169:575-580.
11. Bermudez, L. E. M, A. O. Yau-Young, J. P. Lin, J. Cogger, and L. S. Young. 1990. Treatment of disseminated Mycobacterium avium complex infection of beige mice with liposome encapsulated aminoglycosides. J. Infect. Dis. 161: 1262-1268.
12. Bonventre, P. F., and G. Gregoriadis. 1978. Killing of intraphagocytic Staphylococcus aureus by dihydrostreptomycin entrapped within liposomes. Antimicrob. Agents Chemother. 13:1049-1051.
13. Cynamon, M. H., C. E. Swenson, G. S. Palmer, and R. S. Ginsberg. Liposome encapsulated amikacin therapy of Mycobacterium avium complex infections in beige mice. Antimicrob. Agents Chemother. 33:1179-1183.
14. Dautzenberg, B. 1994. Clinical trials in Mycobacterium avium therapy: lessons to take home. Res. Microbiol. 145:197-206.
15. Düzgünes, N., D. R. Ashtekar, D. L. Flasher, N. Ghori, R. J. Jacobs, D. S. Friends, and P. R. Gangadharam. 1991. Treatment of Mycobacterium avium-intracellulare complex infection in beige mice with free and liposomal encapsulated streptomycin: role of liposome type and duration of treatment. J. Infect. Dis. 164:143-151.
16. Ellner, J. J., M. J. Goldberger, and D. M. Parenti. 1991. Mycobacterium avium infection and AIDS; a therapeutic dilemma in rapid evolution. J. Infect. Dis. 163:1326-1335.
17. Gallets, J. C. 1991. Clofazimine: a review of its use in leprosy and Mycobacterium avium complex infection. Ann. Pharmacother. 25:525-531.
18. Gangadharam, P. R., and E. R. Candler. 1977. Activity of some antileprosy compounds against Mycobacterium intracellulare in vitro. Am. Rev. Respir. Dis. 115:705-708.
19. Gangadharam, P. R., D. A. Ashtekar, N. Ghori, J. A. Goldstein, R. J. Debs, and N. Düzgünes. 1991. Chemotherapeutic potential of free and liposome encapsulated streptomycin against experimental Mycobacterium avium complex infections in beige mice. J. Antimicrob. Chemother. 28:425-435.
20. Gangadharam, P. R. J. 1995. Beige mouse model for Mycobacterium avium complex disease. Antimicrob. Agents Chemother. 39:1647-1654.
21. Gomez-Flores, R., S. D. Tucker, R. Kansal, R. Tamez-Guerra, and R. T. Mehta. Enhancement of antibacterial activity of clofazimine against Mycobacterium avium-M. intracellulare complex infection induced by IFN-γ is mediated by TNF-α. J. Antimicrob. Chemother., in press.
22. Horsburgh, C. R., and R. M. Selik. 1989. The epidemiology of disseminated non tuberculous mycobacterial infection in the acquired immunodeficiency syndrome (AIDS). Am. Rev. Respir. Dis. 139:4-7.
23. Klemens, S. P., M. H. Cynamon, C. E. Swenson, and R. S. Ginsberg. 1990. Liposome encapsulated gentamycin therapy of Mycobacterium avium complex infection in beige mice. Antimicrob. Agents Chemother. 34:967-970.
24. Krajewska, M. M., R. Anderson, and J. F. O'Sullivan. 1993. Effect of clofazimine analogues and tumor necrosis factor-α individually and in combination on human polymorphonuclear leukocyte functions in vitro. Int. J. Immunopharmacol. 15:99-111.
25. LeConte, P., F. LeGallou, G. Potel, L. Struillou, D. Baron, and H. B. Drugeon. 1994. Pharmacokinetics, toxicity and efficacy of liposomal capreomycin in disseminated Mycobacterium avium beige mouse model. Antimicrob. Agents Chemother. 38:2695-2701.
26. Lopez-Berestein, G., G. P. Bodey, L. S. Frankel, and K. Mehta. 1987. Treatment of hepatosplenic candidiasis with liposomal amphothericin B. J. Clin. Oncol. 5:310-317.
27. Lopez-Berestein, G., V. Fainstein, R. Hopfer, K. Mehta, M. P. Sullivan, M. Keating, M. G. Rosenblum, R. Mehta, M. Luna, and E. M. Hersh. 1995. Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study. J. Infect. Dis. 151:704-710.
28. Macher, A. M., J. A. Kovacs, V. Gill, G. D. Roberts, J. Ames, C. H. Park, S. Straus, H. C. Lane, J. E. Parrillo, and A. S. Fauci. 1983. Bacteremia due to Mycobacterium avium-intracellulare in the acquired immunodeficiency syndrome. Ann. Intern. Med. 99:782-785.
29. Mehta, R. T. 1996. Liposome encapsulation of clofazimine reduces toxicity in vitro and in vivo and improves therapeutic efficacy in the beige mouse model of disseminated Mycobacterium avium-M. intracellulare complex infection. Antimicrob. Agents Chemother. 40:1893-1902.
30. Mehta, R. T., A. Keyhani, T. J. McQueen, B. Rosenbaum, K. Rolston, and J. J. Tarrand. 1993. In vitro activities of free and liposomal drugs against Mycobacterium avium-M. intracellulare complex and M. tuberculosis. Antimicrob. Agents Chemother. 37:2584-2587.
31. Murray, J. F., C. P. Felton, S. M. Garay, M. S. Gottalieb, P. C. Hopewell, D. E. Strover, and A. S. Teirstein. 1984. Pulmonary complications of the acquired immunodeficiency syndrome. N. Engl. J. Med. 310:1682-1688.
32. Onyeji, C. O., C. H. Nightingale, P. R. Tessier, D. P. Nicolau, and L. M. Bow. 1995. Activities of clarithromycin, aziyhromycin, and ofloxacin in combination with liposomal or unencapsulated granulocyte-macrophage colony stimulating factor against intramacrophage Mycobacterium avium-Mycobacterium intracellulare. J. Infect. Dis. 172:810-816.
33. Peters, J. H., K. J. Hamme, and G. R. Gorden. 1982. Determination of clofazimine in plasma by high-performance liquid chromatography. J. Chromatogr. 229:503-508.
34. Swenson, C. E., M. C. Pepescu, and R. S. Ginsberg. 1988. Preparation and use of liposomes in the treatment of microbial infections. Crit. Rev. Microbiol. 15(Suppl. 1):S1-S31.
35. Tomioka, H., H. Saito, K. Sato, and T. Yoneyama. 1991. Therapeutic efficacy of liposome encapsulated kanamycin against Mycobacterium intracellulare infection induced in mice. Am. Rev. Respir. Dis. 144:575-579.
36. Wiehert, B. V., R. J. Gonzalez-Rothi, L. E. Straub, B. M. Wichert, and H. Schreir. 1992. Amikacin liposomes: characterization, aerosolization and in vitro activity against Mycobacterium avium-intracellulare in alveolar macrophages. Int. J. Pharm. 78:227-235.
37. Young, L. S., C. B. Inderlied, O. G. Berlin, and M. S. Gottlieb. 1986. Mycobacterial infections in AIDS patients with an emphasis on the Mycobacterium avium complex. Rev. Infect. Dis. 8:1024-1033.
38. Young, L. S. 1988. Mycobacterium avium complex infection. J. Infect. Dis. 157:863-867.